APH vs OKUR · P/E 40, rev $23.09B vs P/E 72, $76.6M cap
Amphenol Corporation (APH) versus OnKure Therapeutics, Inc. (OKUR) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
OnKure Therapeutics, Inc. (OKUR) is a biotechnology company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported OKUR revenue for 2024-12-31 was $0. Net income was -$52.7M. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
APH currently screens at market cap $170.77B and trailing P/E 39.9. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
Not investment advice. Open the APH and OKUR stock pages for the full models.
Not investment advice.